Ads
related to: pfizer- Astellas Pharma Support
Learn about our Support Solutions
and find helpful enrollment forms.
- World-Class Products
Discover more about our FDA-
approved treatment options.
- Science and Innovation
View our approach to finding
solutions for cancer's complexities
- Patient Commitment
Our Patient Centricity Team aims to
change the course of cancer care.
- Astellas Pharma Support
Search results
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 6 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 19 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 5 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AOL· 4 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoFree Report) has recently been on Zacks.com's list of the most searched stocks. The Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has gained 6.3% over ...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 18 hours agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...
High salaries, poor performance: These were the most overpaid CEOs last year
Fast Company Magazine· 12 hours agoWhen it comes to CEO salaries, no one topped Broadcom’s Hock Tan last year. Among the worst...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 2 days agoModerna CEO Stéphane Bancel recently told Barron’s that launching the shots in August instead of...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 23 hours agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their...
Motley Fool via Yahoo Finance· 3 days agoHere's a look at two dividend stocks that got lots of attention from billionaires lately to see if...